Canopy Growth Corporation (CGC:NASDAQ) closed at $0.672 on October 21, 2026, down 6.67% on the day. The stock trades 71.8% below its 52-week high of $2.38 and 1.4% above its 52-week low of $0.662. Over the past year, it lost 49.1%. Canopy Growth Corporation is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, CGC closed higher on 91 days (36%). Its best day was December 12, 2025 (+53.98%) and its worst was December 19, 2025 (-12.43%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Find more stocks like CGC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.